Detalhe da pesquisa
1.
T cell-derived interleukin-22 drives the expression of CD155 by cancer cells to suppress NK cell function and promote metastasis.
Immunity;
56(1): 143-161.e11, 2023 01 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36630913
2.
Impact of the selective A2AR and A2BR dual antagonist AB928/etrumadenant on CAR T cell function.
Br J Cancer;
127(12): 2175-2185, 2022 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36266575
3.
Bispecific antibodies redirect synthetic agonistic receptor modified T cells against melanoma.
J Immunother Cancer;
11(5)2023 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37208128